75N91023C00035

SBIR TOPIC #446 PHASE I -DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT

National Institutes of Health · United States

This tender closed on Tuesday, June 30, 2026. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedOtherFederal

Basic information

Reference number: 75N91023C00035
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Other
Title: SBIR TOPIC #446 PHASE I -DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT
Source: USASpending (Federal)
Source ID: usa-75N91023C00035

Details

Location: United States

Description

SBIR TOPIC #446 PHASE I -DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT Awarded to: RIPTIDE THERAPEUTICS LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT

Dates

Publication: 2023/09/25 12:00:00 AM UTC
Closing date: 2026/06/30 12:00:00 AM UTC

Estimated value

$400K USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-05-25, 2:33:01 p.m.

Data refreshed every 2 hours